Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: The discussion covers the implications of the current research of the Human Genome Project and explores the impact on public health. The presentation addresses how the research affects the life insurance industry. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 4

Description: This session is about the impact of health-care reform on supplemental health insurance plans such as Medicare Supplement, Hospital, Cancer, etc. The session will also explore new opportunities for supplementary markets and products. Included is a discussion of the CHAMPUS and FEHBP. From Record of Society of Actuaries Vol. 19, No. 4B.

Description: This session summarizes recent trends in behavioral health parity, pros and cons of parity, the impact of mandated benefits on near-term medical costs and methods to effectively manage mental health utilization. From Record of Society of Actuaries, Vol. 30, No. 1, Session 81

Description: This discussion looks at the causes of the increase of costs in medical care and what can be done to keep these costs under control. Form Transactions of Society of Actuaries 1959, Vol. 11, No. 30 AB.

Description: Attendees learn about the Patient's Bill of Rights, pressures on managed care programs and the strategies being used to address the changing dynamics of the managed care environments. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 116

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: This 1991 panel discussion is about health care trend including current experience, measurement techniques and problems, uses of trend projections, and other considerations such as the impact of selection and the impact of initial and renewal underwriting practices. From the Record of the Society of Actuaries Vol. 17, No. 3A.

Description: This session will discuss the continuing evolution of the managed health care process. Topics include precertification, utilization review, retrospective review, case management, appropriateness review, benchmarking, recredentialing, provider contracting, and integrated medical systems. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This session discussion is about who is the health care manager, how is health care management evaluated, ethical considerations, malpractice liability and data systems support. Inlcudes a discussion on gatekeepers, provider contracting, utilization management, benefit design, DRG creep, long-term care, From Record of the Society of Actuaries 1987 Vol. 13, No. 1.